Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Wigren

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|May 26, 2012
Low levels of circulating CD4+FoxP3+ T cells are associated with an increased risk for development of myocardial infarction but not for strokeMaria Wigren, Harry Björkbacka, Linda Andersson, et al.
BMC Immunology|December 4, 2010
CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe⁻(/)⁻ miceDaniel Kolbus, Ornélia H Ramos, Katarina E Berg, et al.
Circulation Research|September 22, 2007
Involvement of the CD1d-natural killer T cell pathway in neointima formation after vascular injuryAsa Ström, Maria Wigren, Anna Hultgårdh-Nilsson, et al.
Scientific Reports|May 19, 2016
Treatment with a GnRH receptor agonist, but not the GnRH receptor antagonist degarelix, induces atherosclerotic plaque instability in ApoE(-/-) miceAnki Knutsson, Sabrina Hsiung, Selvi Celik, et al.
Diabetes & Vascular Disease Research|December 22, 2018
Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular diseaseSara Rattik, Daniel Engelbertsen, Maria Wigren, et al.
Clinical and Experimental Immunology|May 12, 2015
Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosusElisabet Svenungsson, Daniel Engelbertsen, Maria Wigren, et al.
Frontiers in Immunology|October 30, 2023
Tolerogenic dendritic cells generated <i>in vitro</i> using a novel protocol mimicking mucosal tolerance mechanisms represent a potential therapeutic cell platform for induction of immune toleranceGillian Dao Nyesiga, Lieneke Pool, Pavlos C Englezou, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 18, 2017
FADD, Caspase-3, and Caspase-8 and Incidence of Coronary EventsLing Xue, Yan Borné, Ingrid Yao Mattisson, et al.
Atherosclerosis|August 24, 2015
IL-22 affects smooth muscle cell phenotype and plaque formation in apolipoprotein E knockout miceSara Rattik, Karin Hultman, Uwe Rauch, et al.
Stroke|March 12, 2016
Apolipoprotein B-100 Antibody Interaction With Atherosclerotic Plaque Inflammation and Repair ProcessesGiuseppe Asciutto, Maria Wigren, Gunilla Nordin Fredrikson, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Arteriosclerosis, Thrombosis, and Vascular Biology|May 26, 2012
Low levels of circulating CD4+FoxP3+ T cells are associated with an increased risk for development of myocardial infarction but not for strokeMaria Wigren, Harry Björkbacka, Linda Andersson, et al.
BMC Immunology|December 4, 2010
CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe⁻(/)⁻ miceDaniel Kolbus, Ornélia H Ramos, Katarina E Berg, et al.
Circulation Research|September 22, 2007
Involvement of the CD1d-natural killer T cell pathway in neointima formation after vascular injuryAsa Ström, Maria Wigren, Anna Hultgårdh-Nilsson, et al.
Scientific Reports|May 19, 2016
Treatment with a GnRH receptor agonist, but not the GnRH receptor antagonist degarelix, induces atherosclerotic plaque instability in ApoE(-/-) miceAnki Knutsson, Sabrina Hsiung, Selvi Celik, et al.
Diabetes & Vascular Disease Research|December 22, 2018
Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular diseaseSara Rattik, Daniel Engelbertsen, Maria Wigren, et al.
Clinical and Experimental Immunology|May 12, 2015
Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosusElisabet Svenungsson, Daniel Engelbertsen, Maria Wigren, et al.
Frontiers in Immunology|October 30, 2023
Tolerogenic dendritic cells generated <i>in vitro</i> using a novel protocol mimicking mucosal tolerance mechanisms represent a potential therapeutic cell platform for induction of immune toleranceGillian Dao Nyesiga, Lieneke Pool, Pavlos C Englezou, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 18, 2017
FADD, Caspase-3, and Caspase-8 and Incidence of Coronary EventsLing Xue, Yan Borné, Ingrid Yao Mattisson, et al.
Atherosclerosis|August 24, 2015
IL-22 affects smooth muscle cell phenotype and plaque formation in apolipoprotein E knockout miceSara Rattik, Karin Hultman, Uwe Rauch, et al.
Stroke|March 12, 2016
Apolipoprotein B-100 Antibody Interaction With Atherosclerotic Plaque Inflammation and Repair ProcessesGiuseppe Asciutto, Maria Wigren, Gunilla Nordin Fredrikson, et al.
Pageof 3